EUVIMEDEUVIMED entdecken
Crossref

Laparoscopic sleeve gastrectomy combined with montelukast for obese patients with secretory otitis media

Hua-Long Qiang, Xiang-Li Yao, Zhen-Feng Jiang, Wei Wang

World Journal of Gastrointestinal Surgery · 27.06.2026 · 18 (6)

DOI: 10.4240/wjgs.120692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastrointestinal Surgery, online erschienen am 27.06.2026. Verfasst von Hua-Long Qiang und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Obesity is associated with increased risk of otitis media with effusion (OME), potentially due to peritubal fat accumulation and chronic inflammation. Laparoscopic sleeve gastrectomy (LSG) effectively reduces weight but achieves slow early middle ear effusion resolution. Montelukast, a leukotriene receptor antagonist, possesses anti-inflammatory properties that may promote OME recovery. However, rapid weight loss may paradoxically induce patulous eustachian tube, complicating outcome interpretation. We hypothesized that combining LSG with montelukast would accelerate middle ear effusion clearance and improve eustachian tube function without compromising weight loss efficacy. AIM To evaluate LSG combined with montelukast for obese patients with OME regarding recovery, eustachian tube function, and weight loss. METHODS This retrospective cohort study enrolled 112 obese OME patients treated at a tertiary hospital between January 2020 and March 2025. Groups: Control (n = 48, LSG alone) and observation (n = 64, LSG plus oral montelukast 10 mg/day for one month). Outcomes included total weight loss, excess weight loss, middle ear effusion resolution time, air-bone gap, Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) score, 36-Item Short Form Health Survey (SF-36), and adverse events. Assessors were blinded. Inter-group comparisons used t tests and χ 2 tests. RESULTS Baseline characteristics were comparable between groups (P > 0.05). Weight loss outcomes at 1 months and 6 months showed no significant inter-group differences (P > 0.05). Middle ear effusion clearance was significantly faster in the observation group compared to controls (28.39 ± 6.51 days vs 42.10 ± 8.32 days, P < 0.001). At one month postoperatively, the observation group demonstrated superior air-bone gap reduction (18.92 ± 4.65 dB vs 22.04 ± 4.57 dB, P = 0.001) and lower ETDQ-7 scores (2.63 ± 0.97 vs 3.75 ± 1.16, P < 0.001). SF-36 scores favored the observation group at 1 month and 3 months (P < 0.01). Adverse event rates were comparable between groups (7.81% vs 4.17%, P > 0.05). CONCLUSION LSG combined with montelukast significantly accelerates middle ear effusion resolution, improves auditory function and quality of life in obese OME patients, with maintained weight loss and favorable short-term safety.

Zitieren

APA

Qiang, H., Yao, X., Jiang, Z., & Wang, W. (2026). Laparoscopic sleeve gastrectomy combined with montelukast for obese patients with secretory otitis media. World Journal of Gastrointestinal Surgery, 18(6). https://doi.org/10.4240/wjgs.120692

Vancouver

Qiang H, Yao X, Jiang Z, Wang W. Laparoscopic sleeve gastrectomy combined with montelukast for obese patients with secretory otitis media. World Journal of Gastrointestinal Surgery. 2026;18(6). doi:10.4240/wjgs.120692

BibTeX
@article{Qiang2026,
  author = {Qiang, Hua-Long and Yao, Xiang-Li and Jiang, Zhen-Feng and Wang, Wei},
  title = {Laparoscopic sleeve gastrectomy combined with montelukast for obese patients with secretory otitis media},
  journal = {World Journal of Gastrointestinal Surgery},
  year = {2026},
  volume = {18},
  number = {6},
  doi = {10.4240/wjgs.120692}
}
Kostenlos starten →